Oxair addresses global oxygen supply shortage
Concerns over global oxygen supplies are increasing as cases of COVID-19 increase in many parts of the world. Supplies of oxygen in hospitals are being rationed and, in some cases, are at risk of running out.1,2,3
In response, advanced gas process systems manufacturer Oxair is spreading the word about its off-the-shelf solution to potential shortages: Oxygen Pressure Swing Adsorption (PSA) systems.
Oxair’s manufacturing facilities in both Australia and India can turn around orders for ready-to-use, standalone Oxygen PSA units in about 8–10 weeks, depending on local lockdown laws or travel restrictions.
The robust devices are designed to deliver consistent, high-purity oxygen to hospitals and healthcare facilities, even those in remote locations. The plug-and-play system offers a permanent flow of high-quality oxygen, capable of piping oxygen around the hospital to every department as needed, with output pressure of four bar and a flow rate to suit the needs of the hospital. In cases where a hospital does not have a central piping system, Oxair will supply a cylinder filling system, which is reported to be a highly cost-effective and hygienic alternative to cylinders.
The system delivers oxygen of 94–95% purity through PSA filtration, a process that separates oxygen from compressed air. The gas is then conditioned and filtered before being stored in a buffer tank to be used directly by the end user on demand.
“We are ready to step up supplies and prepared to do whatever is necessary to help healthcare services during the current coronavirus crisis — and beyond — by providing this life-saving oxygen equipment wherever it is needed,” Oxair’s David Cheeseman said. “The design of these PSA systems as ‘plug and play’ means that they are literally ready to start working as soon as they are delivered and plugged in — with voltage adapted to the country of delivery. So hospitals can rely on technology which is tried and tested over many years, coupled with almost instant access to vital oxygen supplies.”
Oxfam has warned that wealthy countries must facilitate cheaper mass-produced COVID-19 vaccines...
This winter, for the first time, a new cell-based flu vaccine will be introduced in Australia, in...
Vaccinating surgical patients ahead of the general population has the potential to help avoid...